Summary:
OneStep has secured $36 million to expand its smartphone-based gait analysis technology, aiming to make gait a widely-recognized “sixth vital sign” for health monitoring and disease management.
Key Takeaways:
- Accessible Gait Analysis: OneStep’s technology turns smartphones into clinical-grade tools, providing real-time gait analysis without the need for additional equipment, making it accessible for broad clinical use.
- Health Impact and Early Detection: Gait analysis offers insights into various health conditions, aiding in early detection of diseases like Parkinson’s and Alzheimer’s, and improving patient outcomes through proactive interventions.
- Strategic Growth and Partnerships: With new funding from prominent investors, OneStep plans to scale its technology and expand partnerships across healthcare sectors, strengthening its position as a vital tool in health monitoring.
OneStep announced $36 million in funding to advance its smartphone-based motion analysis technology. This funding positions gait—how a person walks—as the sixth vital sign, crucial for understanding and improving overall health.
OneStep’s technology transforms smartphones into clinical-grade motion analysis tools, making gait analysis as simple as stepping on a bathroom scale. With real-time insights into gait and mobility from anywhere, and without the need for wearables or complex equipment, healthcare providers gain valuable clinical data based on patient movement. This enables timely interventions and keeps patients actively engaged in their health.
Further Reading: OneStep, Mount Sinai Partner on Remote Physical Therapy Study
As life expectancy rises, gait analysis becomes essential for diagnosing and managing chronic conditions. Gait reveals unique insights into the health of body systems, including nervous, musculoskeletal, and cardiorespiratory functions. Early detection of falls, Parkinson’s, Alzheimer’s, and other diseases through gait analysis allows for proactive interventions that can significantly improve quality of life.
OneStep’s FDA-listed, AI-powered care platform offers continuous, real-life monitoring, empowering healthcare providers with actionable, real-time data. Providers can enhance patient outcomes, improve decision-making, streamline documentation, and reduce costs, while also generating new revenue through remote therapeutic monitoring (RTM).
The funding round was co-led by Team8, a global venture-creation and venture capital fund with deep domain expertise in healthcare, fintech, and cybersecurity, and Vintage Investment Partners, a $4B global investment fund known for investing in disruptive technology companies. Existing investors LionBird, Aleph, and 10D also participated in the round, demonstrating their ongoing confidence in OneStep’s technology and its potential. This latest funding will be used to scale OneStep’s operations and further develop its technology, with the goal of establishing gait analysis as a mainstream tool in health monitoring and improvement.
“Motion is life, and understanding it is key to advancing health,” says Tomer Shussman, co-founder and CEO of OneStep. “By empowering healthcare providers with real-time insights into how patients move, we’re helping unlock the power of gait—transforming healthcare to be more proactive, precise, and focused on improving quality of life.”
“OneStep’s gait analysis technology is truly a game-changer in healthcare, perfectly aligning with Vintage’s commitment to investing in innovations that transform patient care,” says Shira Eting, partner at Vintage Investment Partners. “Under Tomer’s visionary leadership, OneStep will expand to new conditions, such as neurology, and to new types of use cases and customers, and will help democratize gait—one of the most important vital signs.”
“OneStep is combining transformative technology, real clinical results, and a clear business strategy to achieve a huge vision—making gait an easily monitored vital sign, critical for many medical conditions,” says Sarit Firon, Team8 Managing Partner. “Team8 is excited to support the team in taking their impressive early achievements in rehabilitation care to many more use cases, improving quality of care for patients, streamlining operations for providers, and making a huge impact in the healthcare market.”
OneStep’s technology is already in use by over 20 leading healthcare providers across key segments, including skilled nursing facilities, outpatient rehabilitation, home care, orthotics, and prosthetics. These partnerships have demonstrated clear improvements in clinical outcomes and operational efficiency, notably reducing falls and enhancing patient recovery. With a clear product-market fit and a growing presence in its core focus verticals in the U.S., the company believes OneStep is poised to become an industry standard.
To learn more about OneStep and its gait analysis technology, visit https://www.onestep.co/.
